ARTICLE | Company News
NICE rebuffs Avastin for colorectal cancer
November 13, 2010 1:03 AM UTC
The U.K.'s NICE issued a final appraisal determination recommending against the use of Avastin bevacizumab from Roche (SIX:ROG; OTCQX:RHHBY) in combination with oxaliplatin and either 5-fluorouracil p...